Transfemoral TAVI using the JenaValve Trilogy system with controlled deflection and rotational repositioning resulted in no paravalvular leak and excellent hemodynamic outcome in a 46-year-old patient.
Case Report (n=1)
Does transfemoral TAVI using the JenaValve Trilogy system improve hemodynamic outcomes in a patient with severe native aortic regurgitation due to cusp perforation after healed infective endocarditis?
Transfemoral TAVI using the JenaValve Trilogy system is feasible and can achieve excellent hemodynamic outcomes without paravalvular leak in patients with severe native aortic regurgitation complicated by cusp perforation.
BACKGROUND: Severe native aortic regurgitation due to cusp perforation after healed infective endocarditis presents challenges for transcatheter aortic valve implantation (TAVI), particularly without annular calcification. CASE SUMMARY: A 46-year-old patient with healed infective endocarditis presented with severe eccentric aortic regurgitation due to perforation of the left coronary cusp. Given prohibitive surgical risk, transfemoral TAVI using the JenaValve Trilogy system was performed. Controlled deflection and rotational repositioning enabled coaxial alignment of the valve above the native cusps prior to deployment, resulting in no paravalvular leak and excellent hemodynamic outcome. DISCUSSION: This case highlights the technical challenges of TAVI in aortic regurgitation with cusp perforation and demonstrates how leaflet-locator anchoring, delivery system deflection, and multimodality imaging enable safe and effective valve positioning. TAKE-HOME MESSAGE: Cusp perforation may cause locator misengagement during TAVI; controlled deflection and repositioning are critical to achieve safe, stable deployment.
Chan et al. (Wed,) conducted a case report in Severe native aortic regurgitation due to cusp perforation after healed infective endocarditis (n=1). Transfemoral TAVI using the JenaValve Trilogy system was evaluated on Hemodynamic outcome and paravalvular leak. Transfemoral TAVI using the JenaValve Trilogy system with controlled deflection and rotational repositioning resulted in no paravalvular leak and excellent hemodynamic outcome in a 46-year-old patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: